Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.
Making ZMapp: Production of Experimental Drug to Treat Ebola Is Now A Priority
Manufacturing drugs from biological sources sometimes can't be rushed, even when a rare disease becomes more widespread.
New Tax Rules May Deter Future Pharma M&A
Inversions in the pharmaceutical sector could become less lucrative as a result of new tax laws.
NIH Seeks to Improve Vaccine Response with New Adjuvants
NIH seeks new therapeutic products to bolster the protective properties of vaccines.
New Report Details Players and Pipelines in the Biosimilar Space
A new Thomson Reuters BioWorld report outlines the more than 700 biosimilars that are currently in development and the emerging business opportunities that exist in the biopharmaceutical space.